Skip to content

Impact of Dexamethasone Route of Administration on Ropivacaine Analgesia in Brachial Plexus Block

Impact of Dexamethasone Route of Administration on Ropivacaine Analgesia in Brachial Plexus Block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105043
Enrollment
Unknown
Registered
2025-06-27
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after fracture surgery

Interventions

PO -DEX group:Oral dexamethasone
IV-DEX group:Intravenous dexamethasone

Sponsors

Wenzhou People's Hospita
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adults who have had unilateral forearm or hand bone surgery; 2. ASA Rating: 1-3; 3. BMI is 18-30kg.m^2 (minimum weight 50kg);

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. Patients who are unable to provide informed consent; 3. Patients with contraindications to brachial plexus block (e.g., impaired respiratory function, infection at the puncture site, or a history of brachial plexus injury); 4. Patients with contraindications to dexamethasone use (e.g., poorly controlled hypertension or diabetes, gastric or duodenal ulcers, severe electrolyte imbalance); 5. Patients allergic to the study drug or local anesthetics; 6. Patients taking more than 30 mg of oral morphine equivalents per day; 7. Patients taking more than 5 mg of oral prednisone equivalents per day; 8. Patients with a history of alcohol or drug abuse; 9. Glaucoma; 10. Patients who require other surgical interventions during the study period; 11. Trauma patients who require opioid therapy during the study period;

Design outcomes

Primary

MeasureTime frame
the time from removal of the block needle until the first sensation of pain in the surgical area (numerical rating scale > 0).;

Secondary

MeasureTime frame
Pain scores;Postoperative nausea and vomiting;Serious adverse events 30 days after surgery;Blood sugar levels;Cumulative oral morphine equivalent;Sleep quality on the first and second night after surgery;Biceps motor recovery time;Adverse events 48 hours postoperatively;

Countries

China

Contacts

Public ContactQian Zhuo

Wenzhou People's Hospita

13587657628@163.com+86 13587657628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026